您的购物车当前为空
别名 PF-4856264, PF4856264, PF04856264
PF-04856264是一种Nav1.7阻断剂,Nav1.7是软骨细胞调节剂和骨关节炎的治疗靶点,抑制Nav1.7可调节细胞内Ca 2+信号传导和软骨细胞分泌组,提高机械痛阈值并抑制ERK表达,具有镇痛和抗炎作用。


为众多的药物研发团队赋能,
让新药发现更简单!
PF-04856264是一种Nav1.7阻断剂,Nav1.7是软骨细胞调节剂和骨关节炎的治疗靶点,抑制Nav1.7可调节细胞内Ca 2+信号传导和软骨细胞分泌组,提高机械痛阈值并抑制ERK表达,具有镇痛和抗炎作用。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 483 | In Stock | |
| 5 mg | ¥ 1,160 | In Stock | |
| 10 mg | ¥ 1,880 | In Stock | |
| 25 mg | ¥ 3,790 | In Stock | |
| 50 mg | ¥ 5,430 | In Stock | |
| 100 mg | ¥ 7,390 | In Stock | |
| 200 mg | ¥ 9,990 | In Stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,270 | In Stock |
PF-04856264 相关产品
| 产品描述 | PF-04856264 is a Nav1.7 blocker.Nav1.7 is a chondrocyte modulator and a therapeutic target in osteoarthritis.Inhibition of Nav1.7 modulates intracellular Ca 2+ signaling and chondrocyte secretome, raises the threshold of mechanical pain and inhibits ERK expression, which has analgesic and anti-inflammatory effects. |
| 靶点活性 | Nav1.7 (human):28 nM, Nav1.7 (dog):42 nM, Nav1.7 (mouse):131 nM |
| 体内活性 | 方法:PF-04856264 (3-30 mg/kg,腹腔注射) 治疗OD1 诱发的自发性疼痛成年雄性 C57BL/6J 小鼠模型,观研究其治疗效果。 |
| 别名 | PF-4856264, PF4856264, PF04856264 |
| 分子量 | 437.5 |
| 分子式 | C20H15N5O3S2 |
| CAS No. | 1235397-05-3 |
| Smiles | N#CC1=CC(=CC=C1OC=2C=CC=CC2C3=CC=NN3C)S(=O)(=O)NC4=NC=CS4 |
| 密度 | 1.44 g/cm3 (Predicted) |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容